Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9321 - 9328 of 11449 results
Registration Begins for American Telemedicine Association’s New Accreditation of Online Medical Services
December 19, 2014| Blog| Viewpoint
On the Ninth Day of Privacy, my true love gave to me....
December 19, 2014| Blog| Viewpoint
Trademark Licensees May Be Protected in a Licensor’s Bankruptcy Even After a “Free and Clear” Sale
December 19, 2014| Advisory| Viewpoint
CMS Issues Rewards and Incentive Guidance to MA Plans
December 18, 2014| Blog| Viewpoint
Turning Your Research Into Something More: Patents Versus Papers
December 17, 2014| Blog| Viewpoint
Enactment Imminent for Section 529A Tax-Exempt Savings Programs for Disabled Beneficiaries
December 17, 2014| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.